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Organisms are predisposed to diﬀerent types in DNA damage. Multiple mechanisms have evolved to deal with the individual DNA
lesions. Translesion synthesis is a special pathway that enables the replication fork to bypass blocking lesions. Proliferative Cell
Nuclear Antigen (PCNA), which is an essential component of the fork, undergoes posttranslational modiﬁcations, particularly
ubiquitylation and sumoylation that are critical for lesion bypass and for ﬁlling of DNA gaps which result from this bypass. A
special ubiquitylation system, represented by the Rad6 group of ubiquitin conjugating and ligating enzymes, mediates PCNA
mono- and polyubiquitylation in response to fork stalling. The E2 SUMO conjugating enzyme Ubc9 and the E3 SUMO
ligase Siz1 are responsible for PCNA sumoylation during undisturbed S phase and in response to fork stalling as well. PCNA
monoubiquitylation mediated by Rad6/Rad18 recruits special polymerases to bypass the lesion and ﬁll in the DNA gaps. PCNA
polyubiquitylationachievedbyubc13-mms2/Rad5inyeastmediatesanerror-freepathwayoflesionbypasslikelythroughtemplate
switch. PCNA sumoylation appears required for this error-free pathway, and it plays an antirecombinational role during normal
replication by recruiting the helicase Srs2 to prevent sister chromatid exchange and hyper-recombination.
1.Introduction
DNA damage is an unavoidable aspect of existence that
results from both endogenous metabolism and exogenous
insults. These include reactive oxygen species and DNA
replication errors, in addition to ionizing radiation, UV light
and mutagenic chemicals. There are multiple specialized
DNA repair pathways that correct various DNA lesions, such
asabasicnucleotides[1],mismatchedbases[2],singlestrand
defects or lesions [3], and double strand breaks (DSBs)
[4]. In certain conditions, the DNA damage may persist
unrepaired until a replication fork collides with it. This is
seen often with DNA interstrand cross-linking (ICL) lesions
which are some of the most toxic types of DNA damage. ICL
lesions are usually repaired in S-Phase, after replication forks
encounterthem[5].OthertypesofDNAdamageobservedat
the single strand level, resulting from UV exposure or certain
chemicals, can also block the replication fork.
The arrested fork usually deals with such collision
utilizing a potentially mutagenic process named Translesion
Synthesis (TLS) [6, 7]. This type of DNA synthesis ensures
relatively uninterrupted replication even in the face of DNA
injury. TLS was initially described in prokaryotes, and
termed Post-Replication Repair (PRR) [8]. In EC o l iTLS
leaves behind single stranded gaps that are repaired at a
subsequent cell cycle stage. Similar gaps have been described
in Eukaryotes aswell [9, 10]. When a replication fork collides
with an ICL or a single strand lesion, a one-ended DSB
may form. This could trigger homology-based repair, also
termed Homologous Recombination (HR), which is another
pathway the fork utilizes to repair DNA lesions particularly
ICLs [11]. The classic DNA polymerases that mediate
undisturbed replication cannot bypass most ssDNA lesions,
and several alternative (atypical) polymerases that mediate
lesion bypass in TLS have been described. The key regulator
of TLS is the replication sliding clamp Proliferative Cell2 Journal of Nucleic Acids
Nuclear Antigen (PCNA). The PCNA trimer holds multiple
proteins that participate in both normal replication and TLS.
The role of PCNA in TLS is governed by posttranslational
modiﬁcations that occur to it in response to an arrested
fork. In this brief paper we describe the process of PCNA
ubiquitylation and sumoylation in response to replication
fork stalling and the impact of these modiﬁcations on TLS.
2.PCNA UbiquitylationinResponse to
Fork StallingLesions
PCNA has been described as the coordinator of the repli-
cating fork [12]. It mediates the recruitment of multiple
factors required for DNA replication and repair. In a seminal
paper, the Jentsch group described the involvement of
PCNA ubiquitylation and sumoylation in TLS [13]. This
Ubiquitylation is mediated by the Rad6 group TLS factors
[13]. It had been known for a long time that Rad6 family was
involved in TLS in Eukaryotes, and that most of its members
display ubiquitin conjugating and ligating activities [14–16].
Protein ubiquitylation has emerged as a widespread process
that impacts a myriad of cellular processes in eukaryotes
[17]. This process starts with binding of the conserved 76
aa peptide ubiquitin to E1 ubiquitin activating enzyme. This
transfers ubiquitin to an E2 conjugating enzyme, which
interacts with an E3 ligase to transfer ubiquitin to a speciﬁc
substrate. The E3 ligase is the determinant of the speciﬁcity
of the substrate to which ubiquitin is attached. Rad6/Rad18
are the E2/E3 complex that mediates PCNA ubiquitylation
at a conserved Lysine164 [13]. It has been shown that this
modiﬁcation increases aﬃnity of TLS DNA polymerases to
PCNA which contributes to lesion bypass [18]. This was
initially demonstrated for the human TLS Polymerase eta
(polη) but later was shown to apply to other eukaryotic
polymerases of the Y family, including polymerases ι and κ
whicharenotpresentinyeast[19,20].Thisenhancedaﬃnity
for PCNA by the Y family of TLS DNA polymerases is due
to presence of ubiquitin-binding domains of the UBM or
UBZ types [21] in these polymerases which interact with
the monoubiquitin on PCNA (Figure 1). The major TLS
polymerases in yeast include Rad30, Rev1, Rev3, and Rev7
(Rev7 is the regulatory unit, and Rev3 is the catalytic unit of
Polymerase zeta.) Further discussion of the detailed role of
each TLS polymerase can be found elsewhere [6, 7].
PCNA undergoes further ubiquitylation on the same
Lysine 164 to generate a ubiquitin chain [13]. This polyu-
biquitin chain formation is dependent on the presence of
the monoubiquitin species mediated by Rad6/Rad18 [13].
The ubiquitin molecules within this chain bind each other
through the lysine 63 (K63) of each ubiquitin. This type
of ubiquitin chain is diﬀerent from that of the canonical
ubiquitin chains bound through K48 which are responsible
for substrate degradation by the proteasome system [17].
Although a K63 ubiquitin chain could lead to protein degra-
dation, it has mainly been implicated in non-degradation
pathways such as vesicle excretion, signaling, the immune
response, and diﬀerent forms of DNA repair [17]. PCNA
polyubiquitylation is mediated by another E2/E3 complex
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Figure 1:Forkstallingresultsinmonoubiquitylationofthereplica-
tion clamp PCNA which increases its aﬃnity to a TLS polymerase.
Thelatterreplacesthehigh-ﬁdelityreplicativepolymeraseanditcan
accommodate the lesion even with the risk of generating mutations
in certain circumstances. This Polymerase binds PCNA through its
PIP box and a ubiquitin binding domain.
in the Rad6 pathway of PRR, namely ubc13-mms2/Rad 5
in yeast [13]. A mammalian ubc13-mms2 homologue has
beenknownforyears[15],andtwomammalianhomologues
of Rad5 with E3 ligase and helicase activities (HLTF and
SHPRH) were recently described [22–24]. PCNA polyubiq-
uitylation in the setting of fork-blocking lesions results in a
form of error-free repair believed to be mediated by template
switching (Figure 2)[ 25]. The exact mechanism of such
template switching is unknown, but it appears (at least in
yeast) that there are two pathways: one is Rad52 dependent
and the other is Rad52 independent [26]. A recent study
indicated that Rad5-mediated template switch is appreciated
as X-shaped DNA structure on 2-gel electrophoresis, and
it appears to involve holiday junctions (recombination
intermediates) and HR proteins [27]. Another potential sce-
nario for this error-free pathway is through fork regression
after stalling which has been demonstrated in vitro [28].
Rad5 appears to promote this fork regression. However,
since competent replication checkpoint prevents such fork
regression,itisbelievedtobeunlikelymechanismtomediate
this pathway [29]. Mutant Rad5 or ubc13 yeast strains lack
such error-free repair [13, 25]. PCNA monoubiquitylation
at K164 has been described across all eukaryotic cells, from
budding [13, 30] and ﬁssion yeast [31]t oh u m a n s[ 18],
and includes chicken DT40 cells [32, 33]a n dXenopus laevis
egg extracts [34]. This monoubiquitylation is seen during
normal replication in DT40 and mammalian cells [31, 32]. It
is induced by DNA damage in human cells, and is observed
only after DNA damage in budding yeast [13, 30]. PCNA
polyubiquitylation is clearly seen in yeast after DNA damage,
but has been diﬃcult todemonstrate in mammalian systems,
and often requires over-expression of the E3 ligases to be
observed [22–24]. Evidence of the existence of an error-freeJournal of Nucleic Acids 3
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Figure 2: PCNA polyubiquitination mediates an error-free repair believed to occur due to template switch. The factors that perform this
process are unknown. Holiday Junctions (HJs) appear be intermediates in this pathway [27].
TLSpathwaymediatedbyPCNApolyubiquitylationisclearly
demonstrated in yeast, and such pathway is believed to exist
in higher eukaryotes including mammals. There appear to
be other E3 ligases besides Rad18 that could result in PCNA
monoubiquitylation, and although Rad18 is the major E3
ligase for PCNA monoubiquitylation post DNA damage, a
Rad18 independent monoubiquitylation has been described
[33]. A recent report revealed a contribution of the PCNA
binding E3 ligase CRL4 to PCNA monoubiquitylation, in
vitroandinvivo, inasteadystatewithoutDNAdamage[35].
Inpreliminaryexperiments,wehaveobservedthatdecreased
expression of the DNA repair, protein and E3 ligase Pso4
decreasesPCNAmonoubiquitylation(ShaheenandHromas:
unpublished observation). Finally, PCNA monoubiquityla-
tion has also been noted in G1 phase of cell cycle in response
to ICL agents in a pathway that relies on NER and the TLS
polymerase Zeta [36].
3. The Sumoylation of PCNA in Response to
Fork Stalling
The Small Ubiquitin-like MOdiﬁer (SUMO) is involved in
multiple cellular functions including nuclear transport, sig-
nal transduction, transcription, and genome stability [37]. It
has been shown that the ubiquitin and SUMO modiﬁcations
competeforthesameattachmentsiteonacommonsubstrate
in certain circumstances, such as the case of the NF-κB
inhibitor IκBα, where sumoylation was found to counteract
the proteolytic eﬀect of ubiquitylation [38]. In a screen for
sumoylated proteins, PCNA was identiﬁed as a target of this
modiﬁcation [13]. PCNA from S. cerevisiae is sumoylated
primarily on K164, the same site as ubiquitination, during S
phase even in the absence of DNA damage. This is mediated
by the SUMO-speciﬁc E2 conjugating enzyme Ubc9 and the
SUMO E3 ligase Siz1. K127 on PCNA is also sumoylated
independently of Siz1 although not nearly to the same
extent as K164 [13]. The functional signiﬁcance of PCNA
sumoylation is described only in budding yeast, and its role
in higher organisms is debatable. Although PCNA K164
s u m o y l a t i o ni ss e e ni nc h i c k e nD T 4 0c e l l s[ 32]a n dXenopus
laevis egg extracts [34], it has yet to be reported in human
cells. PCNA SUMO chains have been described but their
function is uncertain [30].
It was ﬁrst suggested that PCNA sumoylation favors the
repair of fork blocking lesions by a mutagenic TLS pathway
over an error-free recombination based pathway. This is
shown through investigating the RAD6 pathway mutants
which are highly sensitive to various DNA-damaging agents,
but this sensitivity is partially rescued by blocking PCNA
sumoylation,inamannerdependentonhomologousrecom-
bination [30, 39]. A yeast antirecombination helicase (Srs2)
was identiﬁed as a suppressor of mutant Rad6 phenotype,
in a manner dependent on HR [40]. Subsequently, it
was shown that Srs2 binds sumoylated PCNA through its
sumo-interacting motif, and this may explain the function
of sumoylated PCNA during physiologic replication in
preventing deleterious hyper-recombination [41, 42]. The
lack of PCNA sumoylation leads to increased spontaneous
sister chromatid recombination during mitotic growth [41,
42] .Ar e c e n ti m p o r t a n ty e a s ts t u d y[ 43] investigated the
requiredfactorstoformsisterchromatidjunctions(expected
to occur during template switching or HR) in the Rad18-
Rad5 mediated damage-bypass, and it identiﬁed the SUMO
conjugating enzyme Ubc9 and sumoylated PCNA as essen-
tial for this process, again dependent on Rad51 and so
potentially on HR [43]. This research suggested the presence
of two error-free pathways mediating lesion bypass: one is
mediated by template switching (which may or may not
involve recombination) and requires PCNA sumoylation4 Journal of Nucleic Acids
and ubiquitination, and also it is genetically stable The
other pathway operates when the ﬁrst pathway is defective,
and depends on Rad51 recombination and it is genetically
unstable, and could lead to chromosomal translocation [43–
45]. Another investigation demonstrated that sumoylation
of PCNA could interfere with its association with another
protein, Eco1 which is important for the establishment of
chromatid cohesion during replication [46]. Blocking PCNA
sumoylation partially rescues the temperature sensitivity of
some Eco1 mutants [47]. It is also believed that the binding
of the E2 SUMO ligase Ubc9 to PCNA-on a critical region
may block the binding of other PCNA interacting proteins
[12]. All the above may indicate that sumoylation of PCNA
also plays a key regulatory role in recombination and thus
genomic stability.
4. What Types of DNA Lesions Do Trigger
PCNA Modiﬁcation?
PCNA ubiquitylation and sumoylation are triggered by a
wide variety of DNA lesions that block the replication fork,
such as the ones caused by alkylating chemicals (e.g., methyl-
methanesulfonate (MMS) and 4-nitroquinoline oxide),
bulky adducts such as benzo[a]pyrene dihydrodiol epoxide
(BPDE), hydrogen peroxide (which produces oxidative dam-
age), UV light (producing photoproducts) and ICL agents
[13, 30, 47]. Nucleotide depletion such as the one achieved
by hydroxyurea (HU), which causes a fork stalling and
subsequent collapse, can also induce PCNA modiﬁcation.
However, HU is a weaker trigger of PCNA monoubiqui-
tylation when compared to ICL or alkylating agents [48].
PCNA modiﬁcation is tightly connected to replication since
chemicals that cause direct DNA DSBs, such as bleomycin,
do not cause PCNA ubiquitination or sumoylation [47, 49].
ThetopoisomeraseIinhibitorcamptothecandoesnottrigger
PCNAubiquitylationeventhoughitblocksforkprogression,
by collision with the camptothecin/Topo I complex [47, 49].
Thisledtothesuggestionthattheuncouplingofforkhelicase
activity and polymerase movement is the actual trigger of
PCNA ubiquitylation [50]. This uncoupling creates ssDNA
that binds the Replication Protein A (RPA), which recruits
Rad18,tothestalledfork.RPAhasbeenshowntoberequired
for TLS to proceed across multiple types of DNA lesions [44,
46]. Camptothecin triggers some PCNA ubiquitylation in S.
pombe [31], but this modiﬁcation is minimally above the
normalS-phaseubiquitinsignalthatisseeninthisorganism.
Ionizing Radiation (IR) triggers PCNA ubiquitylation in
budding and ﬁssion yeast [30, 31] but not in mammalian
cells [18, 49]. As mentioned above, in S. cerevisiae, PCNA is
sumoylated in S phase without DNA damage while PCNA
ubiquitylation is noted during S phase in S. Pombe,a n d
higher eukaryotes including humans [13, 30, 31, 47, 49].
5. The Relation betweenPCNA Ubiquitylation
andthe Kinetics of TLS
Traditionally, TLS is envisioned as an alternative replication
process by which the stalled fork can bypass a lesion. PCNA
ubiquitylation is imagined as facilitating this bypass by
recruiting low-ﬁdelity polymerases. However, recent lines
of evidence suggest that PCNA ubiquitylation may play its
major role in ﬁlling in the gaps generated in PRR by utilizing
these TLS polymerases. One study, using 2-D gel and
electron microscopy to probe repair intermediates, revealed
that UV-irradiated S. cerevisiae cells uncouple leading and
lagging strand replication at irreparable UV lesions, thus
generating long ssDNA regions on one side of the fork [51].
Small ssDNA gaps accumulate along the replicated duplexes,
likely resulting from repriming events on both leading and
lagging strands. It was concluded that TLS and homologous
recombination factors counteract gap accumulation without
aﬀecting fork progression [51]. Recent work revealed that
limiting the mutagenic or error-free pathways of TLS to
the G2/M phases of the cell-cycle promote eﬃciently lesion
tolerance indicating that both branches of the DNA damage
tolerance operate eﬀectively after chromosomal replication,
outside S phase [52]. Another elegant study using an
inducible system of DNA damage bypass in S. cerevisiae
demonstrated that TLS occur predominantly during S-phase
but it is separable in time and space from genome replication
[53] .T h es a m es t u d yf o u n dt h a tb o t hd u r i n ga n da f t e r
S phase, ultraviolet-radiation-induced lesions are bypassed
predominantly via error-prone translesion synthesis whereas
the error-free pathway functions as a backup system. The
process of bypassing the lesion itself may rely more on
other factors rather than on modiﬁed PCNA. For instance,
using the genetically tractable chicken cell line DT40, it
was shown that TLS at stalled replication forks requires
both Rev1 translesion polymerase-interaction domain and
ubiquitin-binding domain in its C terminus. Surprisingly,
however, PCNA ubiquitylation was not required to maintain
normal fork progression on damaged DNA. Conversely,
PCNA ubiquitylation was essential for ﬁlling PRR gaps [54].
Rev1 may recruit other essential TLS components through
its multifunctional domains required for lesion bypass. On
the other hand, it was demonstrated that the level of
Rev1 protein is extremely low during G1 and rises slowly
throughout early and mid-S phase but begins to increase
rapidly only in late S phase, reaching a maximum level
in G2. Its level is then maintained at a high intracellular
concentration throughout mitosis until after telophase [55].
DNA damage causes Rev1 to accumulate earlier in S phase
without signiﬁcantly aﬀecting the level reached in G2/M
phase. This is also suggestive of a role in PRR in G2 rather
than S phase, as would be predicted [55]. This cell cycle
regulation of Rev1 is seen mainly in yeast and has not
been demonstrated in higher eukaryotes. Notice that, Rev1
catalytic activity may be dispensable for TLS [56], and this
protein may play its major role in TLS as a scaﬀold that
attracts other TLS polymerases [57]. Overall, the picture is
still nebulous regarding the exact kinetics of TLS/PRR in
eukaryotes. Future studies may shed light on the detailed
mechanisms of lesion bypass.
With the sequence of events that build up at the stalled
fork, it was shown that Rad18 binds ssDNA [58], but this
binding is much weaker compared to the binding of RPA to
ssDNA. Thus, it appears that RPA recruits Rad18 to ssDNAJournal of Nucleic Acids 5
[47].Rad18inturnbindsdirectlytoRad6[58,59]toinitiates
PCNA monoubiquitylation, and it also directly binds Rad5
[60], which together with MMS2/Ubc13 [16] mediate PCNA
polyubiquitylation. Fluorescence-based biophysical methods
revealed that mammalian Rad18 becomes immobilized in
nuclear foci only in S phase cells, and that its physical
association with Rad6 or Polymerase eta is appreciated only
in these foci upon DNA damage [61].
6. Other Functions of the Rad6/Rad18 in
DNA Repair
The 9-1-1 checkpoint clamp is a complex with structural
similarity of PCNA. It is implicated in signaling from ssDNA
at the stalled fork to the checkpoint proteins, particularly
Chk1, to activate the replication checkpoint [62, 63]. One
recent report identiﬁed 9-1-1 as a target of Rad6/Rad18
monoubiquitylation in budding yeast upon triggering DNA
damage [64]. This ubiquitylation is involved in control of
global gene regulation in a way reminiscent of the bacterial
SOS response to DNA damage which enhances DNA repair
gene transcription, translesion synthesis, and recombination
[64]. Rad18 was also shown to be recruited to sites of DNA
DSB probably through interaction of its Ubiquitin Binding
domain with ubiquitin chains deposited at the DSB site
[65]. It is shown that Rad18 contributes to homologous
recombination repair of DSB probably through direct inter-
action with the recombinase RAD51C [65]. Furthermore,
evidence implicates Rad18 in HR since chicken T40 deﬁcient
in Rad18 show aberrant gene conversion (the main form of
HR) [66]. In addition, the HR pathway that gets activated
in the absence of rad18 is a defective one and may lead to
genetic instability [43, 66]. Rad18 appears to suppress an
NHEJ pathway when DSB is induced at the fork level to
promote repair by HR [67]. It seems from all the above
that Rad6/Rad18 play key roles in coordinating several DNA
damage response pathways through ubiquitylation of two
DNA clamps, PCNA and 9-1-1, as well as other unidentiﬁed
targets.
7. The Role of USP1 inPCNA Deubiquitylation
USP1 was identiﬁed in a screen for the ubiquitin protease
which mediates the removal of monoubiquitin from ubiqui-
tylated Fanconi anemia group D2 (Fancd2 is ubiquitylated
in response to fork stalling, and it contributes to TLS,
particularly in response to ICL lesions.) [68], Subsequently,
USP1 was identiﬁed as a deubiquitylating enzyme for
monoubiquitylated PCNA as well [48]. USP1 gets cleaved,
and subsequently degraded by the proteasome system in
response to UV light exposure, but not to alkylating or
cross-linking agents [48, 68]. It is believed that there is a
steady-state level of PCNA ubiquitylation by Rad6-Rad18
which is continuously antagonized by USP1, and when
USP1 level goes down post-UV exposure, this leads to
detectable PCNA ubiquitylation. Contrary to prediction,
USP1 deletion leads to DNA damage sensitivity [69], and
mice deﬁcient in USP1 display DNA damage phenotype
reminiscent of Fanconi anemia [70]. This defective DNA
repair is associated with constitutively chromatin-bound
monoubiquitylated FANCD2. In contrast, persistent PCNA
monoubiquitylation has negligible impact on DNA repair
or mutagenesis [69]. The molecular mechanism of this
phenotype is uncertain. It is worth mentioning that PCNA
ubiquitylation occurs earlier after UV light than that after
chemical exposure, and it persists for a long time (at least
48 hours) after a single exposure to diﬀerent DNA damaging
agents ([48, 49], and our observation).
8. Does the Replication Checkpoint
ActivatePCNAUbiquitylation?
The replication checkpoint gets activated in response to
situations that cause replication fork stalling in S phase.
ATR (Ataxia Telangiectasia and Rad3-related) protein plays
a central role in activating this checkpoint. The exposed
ssDNA at the fork recruits RPA, which, in turn, recruits
ATRIP (ATR-Interacting Protein), and that brings in ATR,
which phosphorylates and activates Chk1 [62, 63]. The
PCNA-like replication clamp (the 9-1-1 complex), whose
loader interacts with RPA, also contributes to ATR and
Chk1 activation. ATR and Chk1 phosphorylate multiple
proteins to among other functions stabilize the stalled fork,
suppress the late-ﬁring origins of replications, halt cell cycle
progression, and induce repair pathways, [62, 63]. In yeast
and lower eukaryotes, it has been shown that this checkpoint
activation does not alter the status of PCNA ubiquitylation
[31, 47, 50]. In other words, checkpoint activation in yeast
could be prevented by suppressing ATR or Chk1 without
impacting PCNA ubiquitylation in response to fork stalling.
In mammalian systems, the picture is less clearer. One report
demonstrated 60% reduction in PCNA monoubiquitylation
triggered by chemical DNA damage when ATR or Chk1
levels were reduced by siRNA [20]. Another study failed
to show a change in the PCNA-monoubiquitin level upon
reducing ATR levels [49], but did ﬁnd a reduction when
RPA was reduced. Thus, RPA appears to be instrumental
for PCNA ubiquitylation to be induced [47, 49]. PTIP/Swift,
an adaptor protein for the checkpoint kinases ATM and
ATR, appears to contribute to PCNA ubiquitylation in
human cells and X. laevis e g ge x t r a c t ss i n c ed e p l e t i o no f
PTIP/Swift results in a reduction in this modiﬁcation [71].
The cell cycle inhibitor p21 binds PCNA, and its down-
regulation is required for PCNA monoubiquitylation upon
DNA damage [72]. On the other hand, a contradictory
study showed that depleting p21 or p53 results in a decrease
in PCNA monoubiquitylation post-UV exposure [73]. The
mechanismsoftheseconﬂictingeﬀectsareunknown,butitis
worth mentioning that one of these two studies exogenously
over-expressed p21 and this could have contributed to
the diﬀerence in outcome [72]. One report indicated that
replication checkpoint proteins are dispensable for TLS to
proceedinyeast[74];however,ifthereisadeﬁciencyofNER,
then repair of ssDNA lesions is heavily tilted toward TLS,
and checkpoint proteins enhance the repair by TLS in this
situation [74, 75].6 Journal of Nucleic Acids
9. SummaryandFutureDirections
Research in TLS/PRR has progressed through multiple stages
over the past 5 decades, from its description in bacteria and
then eukaryotes, to discovering its mechanisms in bacteria
and yeast. A key step in this ﬁeld was the identiﬁcation
of Rad6 as essential for TLS in eukaryotes. This led to
the report [13] that described the fundamental role of the
Rad6 group in ubiquitylating PCNA. The identiﬁcation of
PCNA posttranslational modiﬁcations opened the door for
a cascade of other studies into the role of modiﬁed PCNA in
TLSandthemechanismofthat.However,therearequestions
that remain to be answered about the details of the error-
free pathway of TLS, and the timing of events that take
place at the stalled fork. There is no doubt that ongoing
research in this area will come up with explanations for
all these questions that may or may not agree with current
predictions. It is noteworthy to mention that research in this
ﬁeld has also enriched our understanding of the mechanisms
ofmutagenesis,andtheimplicationsofthatincarcinogenesis
and cancer therapy.
References
[1] A. B. Robertson, A. Klungland, T. Rognes, and I. Leiros,
“Base excision repair: the long and short of it,” Cellular and
Molecular Life Sciences, vol. 66, no. 6, pp. 981–993, 2009.
[2] G.-M. Li, “Mechanisms and functions of DNA mismatch
repair,” Cell Research, vol. 18, no. 1, pp. 85–98, 2008.
[3] T. Nouspikel, “DNA repair in mammalian cells: nucleotide
excision repair: variations on versatility,” Cellular and Molec-
ular Life Sciences, vol. 66, no. 6, pp. 994–1009, 2009.
[4] C. Wyman and R. Kanaar, “DNA double-strand break repair:
all’swellthatendswell,”Annual Review of Genetics,vol.40,pp.
363–383, 2006.
[5] M. R¨ aschle, P. Knipsheer, M. Enoiu et al., “Mechanism of
replication-coupled DNA interstrand crosslink repair,” Cell,
vol. 134, no. 6, pp. 969–980, 2008.
[6] E. C. Friedberg, “Suﬀering in silence: the tolerance of DNA
damage,” Nature Reviews Molecular Cell Biology, vol. 6, no. 12,
pp. 943–953, 2005.
[7] A. R. Lehmann, A. Niimi, T. Ogi et al., “Translesion synthesis:
Y-family polymerases and the polymerase switch,” DNA
Repair, vol. 6, no. 7, pp. 891–899, 2007.
[8] W. D. Rupp and P. Howard-Flanders, “Discontinuities in the
DNA synthesized in an excision-defective strain of Escherichia
coli following ultraviolet irradiation,” Journal of Molecular
Biology, vol. 31, no. 2, pp. 291–304, 1968.
[9] L. Prakash, “Characterization of postreplication repair in
Saccharomyces cerevisiae and eﬀects of rad6, rad18, rev3 and
rad52mutations,”MolecularandGeneralGenetics,vol.184,no.
3, pp. 471–478, 1981.
[10] C. Lawrence, “The RAD6 D N Ar e p a i rp a t h w a yi nSaccha-
romyces cerevisiae: what does it do, and how does it do it?”
BioEssays, vol. 16, no. 4, pp. 253–258, 1994.
[11] X. Li and W.-D. Heyer, “Homologous recombination in DNA
repair and DNA damage tolerance,” Cell Research, vol. 18, no.
1, pp. 99–113, 2008.
[12] G.-L. Moldovan, B. Pfander, and S. Jentsch, “PCNA, the
maestro of the replication fork,” Cell, vol. 129, no. 4, pp. 665–
679, 2007.
[13] C. Hoege, B. Pfander, G.-L. Moldovan, G. Pyrowolakis,
and S. Jentsch, “RAD6-dependent DNA repair is linked to
modiﬁcation of PCNA by ubiquitin and SUMO,” Nature, vol.
419, no. 6903, pp. 135–141, 2002.
[14] S. Jentsch, J. P. McGrath, and A. Varshavsky, “The yeast DNA
repair gene RAD6 encodes a ubiquitin-conjugating enzyme,”
Nature, vol. 329, no. 6135, pp. 131–134, 1987.
[15] R. M. Hofmann and C. M. Pickart, “Noncanonical MMS2-
encoded ubiquitin-conjugating enzyme functions in assembly
of novel polyubiquitin chains for DNA repair,” Cell, vol. 96,
no. 5, pp. 645–653, 1999.
[16] H. D. Ulrich and S. Jentsch, “Two RING ﬁnger proteins
mediate cooperation between ubiquitin-conjugating enzymes
in DNA repair,” The EMBO Journal, vol. 19, no. 13, pp. 3388–
3397, 2000.
[17] C. M. Pickart and M. J. Eddins, “Ubiquitin: structures,
functions, mechanisms,” Biochimica et Biophysica Acta, vol.
1695, no. 1-3, pp. 55–72, 2004.
[18] P. L. Kannouche, J. Wing, and A. R. Lehmann, “Interaction of
human DNA polymerase η with monoubiquitinated PCNA:
a possible mechanism for the polymerase switch in response
to DNA damage,” Molecular Cell, vol. 14, no. 4, pp. 491–500,
2004.
[19] B. S. Plosky, A. E. Vidal, A. R. F. de Henestrosa et al.,
“Controlling the subcellular localization of DNA polymerases
ι and η via interactions with ubiquitin,” The EMBO Journal,
vol. 25, no. 12, pp. 2847–2855, 2006.
[20] X. Bi, L. R. Barkley, D. M. Slater et al., “Rad18 regulates
DNA polymerase κ and is required for recovery from S-phase
checkpoint-mediated arrest,” Molecular and Cellular Biology,
vol. 26, no. 9, pp. 3527–3540, 2006.
[ 2 1 ]M .B i e n k o ,C .M .G r e e n ,N .C r o s e t t oe ta l . ,“ B i o c h e m i s t r y :
ubiquitin-binding domains in Y-family polymerases regulate
translesion synthesis,” Science, vol. 310, no. 5755, pp. 1821–
1824, 2005.
[22] I. Unk, I. Hajd´ u, K. F´ atyol et al., “Human HLTF functions
as a ubiquitin ligase for proliferating cell nuclear antigen
polyubiquitination,” Proceedings of the National Academy of
Sciences of the United States of America, vol. 105, no. 10, pp.
3768–3773, 2008.
[23] I. Unk, I. Hajd´ u, K. F´ atyol et al., “Human SHPRH is a ubiq-
uitinligaseforMms2-Ubc13-dependentpolyubiquitylationof
proliferating cell nuclear antigen,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 103,
no. 48, pp. 18107–18112, 2006.
[24] A. Motegi, H.-J. Liaw, K.-Y. Lee et al., “Polyubiquitination
of proliferating cell nuclear antigen by HLTF and SHPRH
prevents genomic instability from stalled replication forks,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 105, no. 34, pp. 12411–12416, 2008.
[25] H. Zhang and C. W. Lawrence, “The error-free component of
theRAD6/RAD18DNAdamagetolerancepathwayofbudding
yeast employs sister-strand recombination,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 102, no. 44, pp. 15954–15959, 2005.
[26] V. Gangavarapu, S. Prakash, and L. Prakash, “Requirement
of RAD52 group genes for postreplication repair of UV-
damaged DNA in Saccharomyces cerevisiae,” Molecular and
Cellular Biology, vol. 27, no. 21, pp. 7758–7764, 2007.
[27] E. C. Minca and D. Kowalski, “Multiple Rad5 activities
mediate sister chromatid recombination to bypass DNA
damageatstalledreplicationforks,” MolecularCell,vol.38,no.
5, pp. 649–661, 2010.Journal of Nucleic Acids 7
[28] A. Blasty´ a k ,L .P i n t ´ e r ,I .U n k ,L .P r a k a s h ,S .P r a k a s h ,a n d
L. Haracska, “Yeast Rad5 protein required for postreplication
repair has a DNA helicase activity speciﬁc for replication fork
regression,” Molecular Cell, vol. 28, no. 1, pp. 167–175, 2007.
[29] J.M.Sogo,M.Lopes,andM.Foiani,“ForkreversalandssDNA
accumulation at stalled replication forks owing to checkpoint
defects,” Science, vol. 297, no. 5581, pp. 599–602, 2002.
[30] P. Stelter and H. D. Ulrich, “Control of spontaneous and
damage-induced mutagenesis by SUMO and ubiquitin con-
jugation,” Nature, vol. 425, no. 6954, pp. 188–191, 2003.
[ 3 1 ]J .F r a m p t o n ,A .I r m i s c h ,C .M .G r e e ne ta l . ,“ P o s t r e p l i c a t i o n
repairandPCNAmodiﬁcationinSchizosaccharomycespombe,”
Molecular Biology of the Cell, vol. 17, no. 7, pp. 2976–2985,
2006.
[32] H. Arakawa, G.-L. Moldovan, H. Saribasak, N. N. Saribasak,
S. Jentsch, and J.-M. Buerstedde, “A role for PCNA ubiquiti-
nation in immunoglobulin hypermutation,” PLoS Biology, vol.
4, no. 11, pp. 1947–1956, 2006.
[33] L.J.Simpson,A.-L.Ross,D.Sz¨ utset al.,“RAD18-independent
ubiquitination of proliferating-cell nuclear antigen in the
avian cell line DT40,” EMBO Reports, vol. 7, no. 9, pp. 927–
932, 2006.
[34] C. A. Leach and W. M. Michael, “Ubiquitin/SUMO modi-
ﬁcation of PCNA promotes replication fork progression in
Xenopus laevis egg extracts,” Journal of Cell Biology, vol. 171,
no. 6, pp. 947–954, 2005.
[35] K. Terai, T. Abbas, A. A. Jazaeri, and A. Dutta, “CRL4
Cdt2
E3 ubiquitin ligase monoubiquitinates PCNA to promote
translesion DNA synthesis,” Molecular Cell,v o l .3 7 ,n o .1 ,p p .
143–149, 2010.
[36] S. Sarkar, A. A. Davies, H. D. Ulrich, and P. J. McHugh, “DNA
interstrand crosslink repair during G1 involves nucleotide
excision repair and DNA polymerase ζ,” The EMBO Journal,
vol. 25, no. 6, pp. 1285–1294, 2006.
[37] E. S. Johnson, “Protein modiﬁcation by SUMO,” Annual
Review of Biochemistry, vol. 73, pp. 355–382, 2004.
[38] J. M. P. Desterro, M. S. Rodriguez, and R. T. Hay, “SUMO-
1 modiﬁcation of IκBα inhibits NF-κB activation,” Molecular
Cell, vol. 2, no. 2, pp. 233–239, 1998.
[ 3 9 ]L .H a r a c s k a ,C .A .T o r r e s - R a m o s ,R .E .J o h n s o n ,S .P r a k a s h ,
a n dL .P r a k a s h ,“ O p p o s i n ge ﬀects of ubiquitin conjugation
and SUMO modiﬁcation of PCNA on replicational bypass
of DNA lesions in Saccharomyces cerevisiae,” Molecular and
Cellular Biology, vol. 24, no. 10, pp. 4267–4274, 2004.
[40] R. H. Schiestl, S. Prakash, and L. Prakash, “The SRS2
suppressor of rad6 mutations of Saccharomyces cerevisiae acts
by channeling DNA lesions into the RAD52 DNA repair
pathway,” Genetics, vol. 124, no. 4, pp. 817–831, 1990.
[41] B. Pfander, G.-L. Moldovan, M. Sacher, C. Hoege, and S.
Jentsch, “SUMO-modiﬁed PCNA recruits Srs2 to prevent
recombination during S phase,” Nature, vol. 436, no. 7049, pp.
428–433, 2005.
[42] E. Papouli, S. Chen, A. A. Davies et al., “Crosstalk between
SUMO and ubiquitin on PCNA is mediated by recruitment of
the helicase Srs2p,” Molecular Cell, vol. 19, no. 1, pp. 123–133,
2005.
[43] D. Branzei, F. Vanoli, and M. Foiani, “SUMOylation regulates
Rad18-mediated template switch,” Nature, vol. 456, no. 7224,
pp. 915–920, 2008.
[ 4 4 ]A .M o t e g i ,R .S o o d ,H .M o i n o v a ,S .D .M a r k o w i t z ,P .P .
Liu, and K. Myung, “Human SHPRH suppresses genomic
instabilitythroughproliferatingcellnuclearantigenpolyubiq-
uitination,”JournalofCellBiology,vol.175,no.5,pp.703–708,
2006.
[45] A.M otegi,K.K untz,A.Majeed,S.Smith,andK.M yung,“Reg-
ulation of gross chromosomal rearrangements by ubiquitin
and SUMO ligases in Saccharomyces cerevisiae,” Molecular and
Cellular Biology, vol. 26, no. 4, pp. 1424–1433, 2006.
[46] G.-L. Moldovan, B. Pfander, and S. Jentsch, “PCNA controls
establishment of sister chromatid cohesion during S phase,”
Molecular Cell, vol. 23, no. 5, pp. 723–732, 2006.
[ 4 7 ]A .A .D a v i e s ,D .H u t t n e r ,Y .D a i g a k u ,S .C h e n ,a n dH .
D. Ulrich, “Activation of ubiquitin-dependent DNA damage
bypass is mediated by replication protein A,” Molecular Cell,
vol. 29, no. 5, pp. 625–636, 2008.
[48] T. T. Huang, S. M. B. Nijman, K. D. Mirchandani et al., “Reg-
ulation of monoubiquitinated PCNA by DUB autocleavage,”
Nature Cell Biology, vol. 8, no. 4, pp. 339–347, 2006.
[49] A. Niimi, S. Brown, S. Sabbioneda et al., “Regulation of pro-
liferating cell nuclear antigen ubiquitination in mammalian
cells,” Proceedings of the National Academy of Sciences of the
United States of America, vol. 105, no. 42, pp. 16125–16130,
2008.
[50] D.J.Chang,P.J.Lupardus,andK.A.Cimprich,“Monoubiqui-
tination ofproliferating cell nuclear antigen induced by stalled
replication requires uncoupling of DNA polymerase and
mini-chromosome maintenance helicase activities,” Journal of
Biological Chemistry, vol. 281, no. 43, pp. 32081–32088, 2006.
[51] M. Lopes, M. Foiani, and J. M. Sogo, “Multiple mechanisms
control chromosome integrity after replication fork uncou-
plingandrestartatirreparableUVlesions,”MolecularCell,vol.
21, no. 1, pp. 15–27, 2006.
[52] G.I.KarrasandS.Jentsch,“TheRAD6DNAdamagetolerance
pathway operates uncoupled from the replication fork and is
functional beyond S phase,” Cell, vol. 141, no. 2, pp. 255–267,
2010.
[53] Y. Daigaku, A. A. Davies, and H. D. Ulrich, “Ubiquitin-
dependent DNA damage bypass is separable from genome
replication,” Nature, vol. 465, no. 7300, pp. 951–955, 2010.
[54] C. E. Edmunds, L. J. Simpson, and J. E. Sale, “PCNA ubiqui-
tination and REV1 deﬁne temporally distinct mechanisms for
controlling translesion synthesis in the avian cell line DT40,”
Molecular Cell, vol. 30, no. 4, pp. 519–529, 2008.
[55] L. S. Waters and G. C. Walker, “The critical mutagenic
translesion DNA polymerase Rev1 is highly expressed during
G2/M phase rather than S phase,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 103,
no. 24, pp. 8971–8976, 2006.
[56] A.-L. Ross, L. J. Simpson, and J. E. Sale, “Vertebrate DNA
damage tolerance requires the C-terminus but not BRCT or
transferase domains of REV1,” Nucleic Acids Research, vol. 33,
no. 4, pp. 1280–1289, 2005.
[57] C. Guo, P. L. Fischhaber, M. J. Luk-Paszyc et al., “Mouse Rev1
protein interacts with multiple DNA polymerases involved in
translesion DNA synthesis,” The EMBO Journal, vol. 22, no.
24, pp. 6621–6630, 2003.
[58] V.Bailly,J.Lamb,P.Sung,S.Prakash,andL.Prakash,“Speciﬁc
complex formation between yeast RAD6 and RAD18 pro-
teins: a potential mechanism for targeting RAD6 ubiquitin-
conjugating activity to DNA damage sites,” Genes and Devel-
opment, vol. 8, no. 7, pp. 811–820, 1994.
[59] V. Bailly, S. Lauder, S. Prakash, and L. Prakash, “Yeast DNA
repair proteins Rad6 and Rad18 form a heterodimer that
has ubiquitin conjugating, DNA binding, and ATP hydrolytic
activities,” Journal of Biological Chemistry, vol. 272, no. 37, pp.
23360–23365, 1997.
[60] H. D. Ulrich and S. Jentsch, “Two RING ﬁnger proteins
mediate cooperation between ubiquitin-conjugating enzymes8 Journal of Nucleic Acids
in DNA repair,” The EMBO Journal, vol. 19, no. 13, pp. 3388–
3397, 2000.
[ 6 1 ]N .B .W a t s o n ,E .N e l s o n ,M .D i g m a n ,J .A .T h o r n b u r g ,B .
W. Alphenaar, and W. G. McGregor, “RAD18 and associated
proteins are immobilized in nuclear foci in human cells
entering S-phase with ultraviolet light-induced damage,”
Mutation Research, vol. 648, no. 1-2, pp. 23–31, 2008.
[62] S. P. Jackson and J. Bartek, “The DNA-damage response in
human biology and disease,” Nature, vol. 461, no. 7267, pp.
1071–1078, 2009.
[63] D. Branzei and M. Foiani, “Maintaining genome stability at
the replication fork,” Nature Reviews Molecular Cell Biology,
vol. 11, no. 3, pp. 208–219, 2010.
[ 6 4 ]Y .F u ,Y .Z h u ,K .Z h a n g ,M .Y e u n g ,D .D u r o c h e r ,a n dW .
Xiao, “Rad6-Rad18 mediates a eukaryotic SOS response by
ubiquitinating the 9-1-1 checkpoint clamp,” Cell, vol. 133, no.
4, pp. 601–611, 2008.
[65] J.Huang, M.S.Y. Huen, H. Kimet al., “RAD18 transmitsDNA
damagesignallingtoelicithomologousrecombinationrepair,”
Nature Cell Biology, vol. 11, no. 5, pp. 592–603, 2009.
[66] D. Sz¨ uts, L. J. Simpson, S. Kabani, M. Yamazoe, and J. E.
Sale, “Role for RAD18 in homologous recombination in DT40
cells,” MolecularandCellularBiology,vol.26,no.21,pp.8032–
8041, 2006.
[67] A. Saberi, H. Hochegger, D. Szuts et al., “RAD18 and
poly(ADP-ribose) polymerase independently suppress the
access of nonhomologous end joining to double-strand breaks
and facilitate homologous recombination-mediated repair,”
Molecular and Cellular Biology, vol. 27, no. 7, pp. 2562–2571,
2007.
[ 6 8 ]S .M .B .N i j m a n ,T .T .H u a n g ,A .M .G .D i r a ce ta l . ,“ T h e
deubiquitinating enzyme USP1 regulates the fanconi anemia
pathway,” Molecular Cell, vol. 17, no. 3, pp. 331–339, 2005.
[69] V. H. Oestergaard, F. Langevin, H. J. Kuiken et al., “Deubiq-
uitination of FANCD2 is required for DNA crosslink repair,”
Molecular Cell, vol. 28, no. 5, pp. 798–809, 2007.
[70] J.M.Kim,K.Parmar,M.Huangetal.,“Inactivationofmurine
Usp1 results in genomic instability and a Fanconi anemia
phenotype,” Developmental Cell, vol. 16, no. 2, pp. 314–320,
2009.
[71] T. G¨ ohler, I. M. Munoz, J. Rouse, and J. J. Blow, “PTIP/Swift
is required for eﬃcient PCNA ubiquitination in response to
DNA damage,” DNA Repair, vol. 7, no. 5, pp. 775–787, 2008.
[72] G. Soria, O. Podhajcer, C. Prives, and V. Gottifredi,
“P21Cip1/WAF1 downregulation is required for eﬃcient
PCNA ubiquitination after UV irradiation,” Oncogene, vol. 25,
no. 20, pp. 2829–2838, 2006.
[73] S. Avkin, Z. Sevilya, L. Toube et al., “p53 and p21 regulate
error-prone DNA repair to yield a lower mutation load,”
Molecular Cell, vol. 22, no. 3, pp. 407–413, 2006.
[74] V. Pag` es, S. R. Santa Maria, L. Prakash, and S. Prakash, “Role
ofDNAdamage-induced replicationcheckpointinpromoting
lesion bypass by translesion synthesis in yeast,” Genes and
Development, vol. 23, no. 12, pp. 1438–1449, 2009.
[75] A. G. Paulovich, C. D. Armour, and L. H. Hartwell, “The
Saccharomyces cerevisiae RAD9, RAD17, RAD24 and MEC3
genes are required for tolerating irreparable, ultraviolet-
induced DNA damage,” Genetics, vol. 150, no. 1, pp. 75–93,
1998.